Crescent Biopharma (CBIO) DMA 200 (2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | DMA 200 |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 8.86 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 3.95 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 25.90 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 24.60 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 17.52 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 436.06 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 4.42 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 694.72 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 385.64 |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 14.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 22, 2026 | 13.85 |
| May 21, 2026 | 13.80 |
| May 20, 2026 | 13.76 |
| May 19, 2026 | 13.72 |
| May 18, 2026 | 13.69 |
| May 15, 2026 | 13.66 |
| May 14, 2026 | 13.62 |
| May 13, 2026 | 13.58 |
| May 12, 2026 | 13.54 |
| May 11, 2026 | 13.52 |
| May 8, 2026 | 13.49 |
| May 7, 2026 | 13.46 |
| May 6, 2026 | 13.44 |
| May 5, 2026 | 13.41 |
| May 4, 2026 | 13.39 |
| May 1, 2026 | 13.36 |
| Apr 30, 2026 | 13.34 |
| Apr 29, 2026 | 13.29 |
| Apr 28, 2026 | 13.25 |
| Apr 27, 2026 | 13.19 |
| Apr 24, 2026 | 13.13 |
| Apr 23, 2026 | 13.08 |
| Apr 22, 2026 | 13.03 |
| Apr 21, 2026 | 12.97 |
| Apr 20, 2026 | 12.93 |
| Apr 17, 2026 | 12.90 |
| Apr 16, 2026 | 12.87 |
| Apr 15, 2026 | 12.86 |
| Apr 14, 2026 | 12.83 |
| Apr 13, 2026 | 12.82 |
| Apr 10, 2026 | 12.82 |
| Apr 9, 2026 | 12.81 |
| Apr 8, 2026 | 12.79 |
| Apr 7, 2026 | 12.77 |
| Apr 6, 2026 | 12.75 |
| Apr 2, 2026 | 12.72 |
| Apr 1, 2026 | 12.70 |